← Back
Data updated: Mar 10, 2026
COLLEGIUM PHARM INC
Neurology
COLLEGIUM PHARM INC is a specialty pharmaceutical company focused on Neurology. Key products include NUCYNTA ER.
2008
Since
3
Drugs
-
Trials
11
Approved (2yr)
Key Drugs
Recent Activity
NUCYNTA ER 2025-12-22
Labeling
XTAMPZA ER 2025-12-22
Labeling
NUCYNTA 2025-12-22
Labeling
NUCYNTA 2025-12-22
Labeling
NUCYNTA ER 2024-10-31
REMS
XTAMPZA ER 2024-10-31
REMS
NUCYNTA 2024-10-31
REMS
NUCYNTA 2024-10-31
REMS
NUCYNTA ER 2024-06-14
Efficacy
NUCYNTA 2024-06-14
Efficacy
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Neurology 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (2)
Discontinued (1)
Company Info
- First Approval
- 2008-11-20
- Latest
- 2025-12-22
- Applications
- 4